Inhibition of mTORC2 leads to a reduction in the expression of liver CSC markers (epithelial cell adhesion molecule, EpCAM) in hepatocellular carcinoma stem cells (Sunayama et al., 2010; Nishitani et al., 2013). The gene discussed is EPCAM; the disease is hepatocellular carcinoma.